Re-Export of Insulin Not in Dosage Forms

This key economic indicator for the Insulin sector has been recently updated.

  1. United States decreased by 22.6% of Re-Export of Insulin Not in Dosage Forms in 2019, compared to the previous year.
  2. Since 2014 United States Re-Export of Insulin Not in Dosage Forms jumped by 218.3% year on year at $4,155,438.
  3. In 2016 Jordan was ranked number 2 in Re-Export of Insulin Not in Dosage Forms totalising $14,085, from 3 in 2015.

Top Countries in Re-Export of Insulin Not in Dosage Forms

US Dollars - 1993 to 2019

#4 CountriesUS DollarsLastYoY5‑years CAGR
1 #1
United States
4,155,438.00 2019 -22.6 % +218.3 % View data
2 #2
Jordan
14,085.00 2016 NA NA View data
3 #3
United Arab Emirates
544.59 2017 -100.0 % NA View data
4 #4
New Zealand
30.87 2015 NA NA View data
Showing 1 to 4 of 4 countries

Source: United Nations Statistical Office

Go Top